Ionis Pharmaceuticals


Ionis Pharmaceuticals is the leading biopharmaceutical company in RNA-targeted drug discovery and development. We use a proven novel drug discovery platform called antisense to create drugs to treat patients with a wide range of diseases.

Industries

Employees

501-1,000

Links


Org chart

Brett P. Monia
Chief Executive Officer
Collapse
C. Frank Bennett
EVP, Chief Scientific Officer
Elizabeth L. Hougen
Executive Vice President, Chief Financial Officer
Patrick R. O’Neil
Chief Legal Officer and General Counsel
Shannon Devers
Executive Vice President, Chief Human Resources Officer
Tracy Berns
SVP, Chief Compliance & Quality Assurance Officer
Joseph T. Baroldi
Chief Business Officer
Paymaan Jafar-Nejad
Executive Director
Beth Hougen
SVP Of Finance And CFO
Frank Bennett
Chief Scientific Officer
Heather Smith
Senior Executive Assistant To The Chief Executive Officer
Jonathan Birchall
Chief Commercial Officer (cco)
Kyle Jenne
Executive Vice President, Chief Global Product Strategy Officer
Tae - Won Kim
VP, Toxicology
Ken Newman
SVP, Clinical Development
Elias Tsepouridis
SVP, Financial Planning & Analysis
Claus A. Rentel
VP, Analytical Chemistry
Leticia Ferri
VP, Cardiometabolic TA Lead, Medical Affairs
Wayne Sanders
VP, Facilities
Donal Murray
VP, GMP Quality Assurance
Dave Hennessy
VP, Head of Sales - Donidalorsen
Ben Strain
VP, Investor Relations
Jeff Smith
VP, Patient Advocacy
Dave Ecker
VP, Strategic Innovation
Jennifer Franklin
Executive Director
Vanessa Reece Bulcao
Executive Assistant; Svp; Chief Compliance Officer
Wade Walke
Senior Vice President
Michael Pollock
SVP, Head of Europe
Andy McPherson
Executive Director
Berit Powers
Executive Director
Muneet Burke
Executive Director
Eugene Schneider
Executive Vice President, Chief Clinical Development Officer
Hayley Soffer
Vice President Corporate Communications
Erin Lettow
Vice President
Carolyn Mazzitelli
Executive Director

Board & advisors